Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors

Clinical trial NCT07021066 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07021066
Sponsor: SystImmune Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Advanced Pancreatic Ductal Adenocarcinoma Esophageal Adenocarcinoma Biliary Tract Cancer Other Solid Tumors

Start date: 2025-07-30
Primary completion: 2027-02-28
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.